Lecithin Cholesterol Acyltransferase Deficiency: Clinical Trials

62 trials for Lecithin Cholesterol Acyltransferase Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

55 completed, 2 recruiting, 2 terminated, 2 unknown. 50 Phase 1, 4 Not applicable, 2 Early Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 150Completed 47, Recruiting 1, Terminated 1, Withdrawn 1
Not applicable4Completed 2, Terminated 1, Unknown 1
Early Phase 12Completed 1, Unknown 1
Phase 21Completed 1
Phase 31Completed 1
Phase 41Completed 1

Follow Lecithin Cholesterol Acyltransferase Deficiency: new trials by email Literature Review of Lecithin Cholesterol Acyltransferase Deficiency trials Research Report on Lecithin Cholesterol Acyltransferase Deficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants
BMS-986533, Famotidine, Placebo - Healthy Volunteers
Phase 1RecruitingBristol-Myers Squibb1362026-07-132026-07-24
The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers
Fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg - Healthy, Fasting
Phase 1CompletedLG Chem282026-06-112026-09-10
A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants.
balcinrenone/ dapagliflozin, quinidine - Healthy Participants
Phase 1CompletedAstraZeneca142025-05-202025-08-12
Pharmacokinetics of AUX-001 40mg Once-daily in Healthy Subjects Under Fasting and Fed Conditions
AUX-001 40mg once-daily - Chronic Stable Angina
Early Phase 1UnknownAuxilius Pharma sp.z.o.o.162023-11-272024-02-12
A Study to Compare the Relative Bioavailability of Two Iberdomide (CC-220) Formulations and to Assess The Effect Of Food on the Drug Levels of Iberdomide in Healthy Adult Participants
Iberdomide - Healthy Volunteers
Phase 1CompletedBristol-Myers Squibb322023-05-182024-07-26
Development of the Leeds Food Preference Questionnaire in Spanish
Standardized meal - Fasting, Fed
Not applicableUnknownUniversidad de Granada502023-03-072023-05-01
Comparative Bioavailability Study of TAH3311 5 mg Oral Dissolving Film vs ELIQUIS® 5 mg Tablet in Healthy Volunteers
Apixaban 5 mg Oral Dissolving Film (TAH3311) and Tablet (Eliquis®) - Healthy Volunteers, Fasting
Early Phase 1CompletedTAHO Pharmaceuticals Ltd.122022-12-052023-08-18
LCAT (Lecithin Cholesterol Acyl Transferase) Natural History Study
Demographics, diagnosis type, genotype, lipid profile, renal function profile, treatment allocation, ophthalmology exam, country of residence. - LCAT Deficiency
RecruitingUniversity of Pennsylvania402022-08-122026-05-06
Bioequivalence Study of Rivaroxaban 2.5 mg Tablets Under Fasting and Fed Conditions
Rivaroxaban 2.5 mg Test Tablet, Rivaroxaban 2.5 mg Reference Tablet - Healthy Participants
Phase 1CompletedThe Affiliated Hospital of Qingdao University642022-03-162026-09-08
Investigation of Fat Oxidation During Moderate Versus Vigorous Intensity Exercise
Exercise - Healthy, Sedentary Lifestyle
Not applicableCompletedLatvian Institute of Organic Synthesis122018-06-182019-03-06
Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?
Cosyntropin - Adrenal Insufficiency, Cirrhosis
Phase 3CompletedUniversity of Virginia1002018-01-292021-12-09
The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions
Dapagliflozin/metformin XR 5/500mg, Dapagliflozin/metformin XR 5/500 mg, Dapagliflozin/metformin XR 10/1000mg - Healthy Subjects in Fasted and Fed State
Phase 1CompletedAstraZeneca2842017-09-262018-05-30
Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed Conditions
Metformine, Glucophage® Long, Metformin - Bioequivalence
Phase 1CompletedGeropharm282017-06-152018-07-03
Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects
Metformin, Glucophage® - Bioequivalence
Phase 1CompletedGeropharm182017-02-142018-07-03
Use of Breath Acetone aa a Marker of Energy Balance
Fasting condition, Sugar condition, Fat condition - Fasting, Fed
Not applicableCompletedUniversity of Lausanne82016-11-012018-01-04
A Study to Demonstrate Bioequivalence Between a 12-mg Dose of an Oral Suspension Formulation of Perampanel and a 12-mg Tablet Formulation of Perampanel Under Fasted and Fed Conditions in Healthy Subjects
Perampanel - Healthy Subjects
Phase 1CompletedEisai Inc.1002014-09-012015-11-03
AStudy to Evaluate the Bioavailability of PF 04965842 in Healthy Subjects
PF-04965842, PF- 04965842 - Healthy
Phase 1CompletedPfizer122014-06-012014-08-18
Fed Bioequivalence Study of CBZ Formulations
Auration CR Tablets 400 Single Dose-Tegretol CR 400 Single Dose, Tegretol CR 400 Single Dose-Auration CR 400 Single Dose - Bio-equivalence Study, Fed Conditions
Phase 1CompletedCenter for Clinical Pharmacology Research Bdbeq S.A.202014-05-012014-06-17
Characterization Of The Effect Of Food On Palbociclib (PD-0332991) Absorption
Palbociclib administered Fasted, Palbociclib administered Fed high calorie, Palbociclib administered Fed low calorie - Healthy
Phase 1CompletedPfizer282013-07-012013-12-17
HRZE Fasted/Fed in Newly Diagnosed TB
intravenous administration of 1st line TB drugs, day 1 - Tuberculosis
Phase 2CompletedUniversity Medical Center Groningen202013-07-012015-04-08

Showing 20 of 62. Sign in to see all of them.

Narrower conditions

Fasting (16)  ·  Abetalipoproteinemia (1)  ·  Adrenal Insufficiency (1)  ·  Angina, Stable (1)  ·  Atherosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Cholesteryl Ester Transfer Protein Deficiency (1)  ·  Coronary Artery Disease (1)  ·  Fibrosis (1)  ·  Insulin Resistance (1)  ·  Kidney Diseases (1)  ·  Lipid Metabolism, Inborn Errors (1)  ·  Motor Activity (1)  ·  Platelet Glycoprotein IV Deficiency (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (62)  ·  Dyslipidemias (62)  ·  Genetic Diseases, Inborn (62)  ·  Hypoalphalipoproteinemias (62)  ·  Hypolipoproteinemias (62)  ·  Lipid Metabolism Disorders (62)  ·  Metabolic Diseases (62)  ·  Metabolism, Inborn Errors (62)  ·  Nutritional and Metabolic Diseases (62)  ·  Lipid Metabolism, Inborn Errors (61)  ·  Behavior (17)  ·  Feeding Behavior (16)  ·  Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Myocardial Ischemia (2)

Interventions

Lisinopril (3)  ·  Metformin (3)  ·  dapagliflozin (3)  ·  Acetaminophen (2)  ·  Doxycycline (2)  ·  Etodolac (2)  ·  Morphine (2)  ·  Olanzapine (2)  ·  Ondansetron (2)  ·  Tablets (2)  ·  Tramadol (2)  ·  Ultracet (2)  ·  Bisoprolol (1)  ·  Buspirone (1)  ·  Cabergoline (1)

Sponsors

IPCA Laboratories Ltd. (12)  ·  Par Pharmaceutical, Inc. (11)  ·  Dr. Reddy's Laboratories Limited (7)  ·  Pfizer (4)  ·  Actavis Inc. (2)  ·  AstraZeneca (2)  ·  Bristol-Myers Squibb (2)  ·  Geropharm (2)  ·  University of Pennsylvania (2)  ·  Auxilius Pharma sp.z.o.o. (1)  ·  Center for Clinical Pharmacology Research Bdbeq S.A. (1)  ·  Duke-NUS Graduate Medical School (1)  ·  Eisai Inc. (1)  ·  LG Chem (1)  ·  Labopharm Inc. (1)

Countries

United States (16)  ·  India (15)  ·  Canada (6)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Russia (2)  ·  Brazil (1)  ·  China (1)  ·  Indonesia (1)  ·  Latvia (1)  ·  Portugal (1)  ·  Singapore (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Thailand (1)

Top investigators

Dr. Hardik Dave, M.B.B.S. (2)  ·  Dr. Rupesh Vala, M.B.B.S. (2)  ·  Dr. Suhas Khandave, M.D. (2)  ·  Dr. Tarang Shah, M.D. (2)  ·  Eric Masson, Pharm.D. (2)  ·  Marina Cuchel, MD, PhD (2)  ·  Alan S. Marion, MD, PhD (1)  ·  Alpeshkumar Patel, MD (1)  ·  Anthony R Godfrey, Pharm.D. (1)  ·  Antonio R. Pizarro, M.D., (1)  ·  Christian Aumais (1)  ·  Christian Aumais, M.D (1)  ·  Clifford L Ferguson, MD (1)

Results publications

PMID 18201934, PMID 22775199, PMID 23713767, PMID 26179237, PMID 26628614, PMID 26661397, PMID 28204912, PMID 30997650, PMID 35061234

NIH funding

2016 (1), 2023 (1)